M. Schluep

Discipline

Psychologie (10) Gestion et management (3) Sciences de l'information et de la communication (1)

Type de document

Articles (23) Colloques et conférences (2)

Co-auteur

Date

Source

Mot-clé

Patients (21) Multiple sclerosis (21) Patients (21) Human beings (13) maladie (12) maladie (12) adulte (10) adulte (10) Disabilities (9) Methods (8) Methods (8) information (6) Treatment (6) Scores (6) Tallies (6) Months (6) Magnetic resonance imaging (6) Expression (6) Brain (6) Older people (6) cerveau (6) tissu (corporel) (5) temps (durée) (5) analyse (5) Control (5) Weights and measures (5) Time (5) Performance (5) Examinations (5) Evidence (5)

Documents écrit par M. Schluep (24) | parle de M. Schluep (0)

Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study.
A. Bourdin et al. (18 févr. 2021)
Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland - a qualitative study.
A. Bourdin et al. (14 mai 2020)
Promoting transitions of care, safety, and medication adherence for patients taking fingolimod in community pharmacies.
A. Bourdin et al. (18 juil. 2019)
Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.
A. Mathias et al.
EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.
A.S. Clottu et al. (3 janv. 2017)
The Combined Quantification and Interpretation of Multiple Quantitative Magnetic Resonance Imaging Metrics Enlightens Longitudinal Changes Compatible with Brain Repair in Relapsing-Remitting Multiple Sclerosis Patients.
G. Bonnier et al. (2017)
Longitudinal automated detection of white-matter and cortical lesions in relapsing-remitting multiple sclerosis
M. J. Fartaria de Oliveira et al.
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
G. Disanto et al. (2016)
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
A. Mathias et al. (2016)
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
G. Bonnier et al. (2016)
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
G. Bonnier et al. (2015)
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
G. Perriard et al. (2015)
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
G. Bonnier et al.
MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.
S. Simioni et al. (2014)
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
S. Jilek et al. (2013)
Neural substrates of social emotion regulation: a FMRI study on imitation and expressive suppression to dynamic facial signals.
P. Vrticka et al. (2013)
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
S. Simioni et al. (2012)
Predictive modelling of multiple sclerosis based on whole-brain functional connectivity
J. Richiardi et al. (2012)
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
S. Jilek et al. (2010)
Progressive decline of decision-making performances during multiple sclerosis.
S. Simioni et al. (2009)
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
S. Jilek et al. (2008)
Preserved decision making ability in early multiple sclerosis.
S. Simioni et al. (2008)
Perceived behavioral changes in early multiple sclerosis.
F.S. Lima et al. (2007)
Cognition, mood and fatigue in patients in the early stage of multiple sclerosis.
S. Simioni et al. (2007)